Gw. Small et al., APOLIPOPROTEIN-E TYPE-4 ALLELE AND CEREBRAL GLUCOSE-METABOLISM IN RELATIVES AT RISK FOR FAMILIAL ALZHEIMER-DISEASE, JAMA, the journal of the American Medical Association, 273(12), 1995, pp. 942-947
Objective.-Cerebral parietal hypometabolism and left-right asymmetry o
ccur early in the course of Alzheimer disease (AD), and the apolipopro
tein E type 4 allele (APOE epsilon 4) is a risk factor for familial AD
. To determine if APOE epsilon 4 is associated with lowered brain func
tion in nondemented relatives at risk for familiar AD, we studied 12 r
elatives with APOE epsilon 4 and 19 relatives without APOE epsilon 4.
We also compared them with seven patients with probable AD. Design.-Af
ter grouping subjects according to diagnosis and genotype, brain funct
ion measures were compared among groups. Setting.-University medical c
enter. Patients.-At-risk subjects had mild memory complaints, normal c
ognitive performance, and at least two relatives with AD. Subjects wit
h APOE epsilon 4 did not differ from those without APOE epsilon 4 in m
ean age at examination (56.4 vs 55.5 years) or in neuropsychological p
erformance (mean Mini-Mental State Examination score, 28.8 vs 29.3). M
ain Outcome Measures.-Cerebral glucose metabolism was measured using p
ositron emission tomography and fludeoxyglucose F 18. Results.-Parieta
l metabolism was significantly lower and left-right parietal asymmetry
was significantly higher in at-risk subjects with APOE epsilon 4 comp
ared with those without APOE epsilon 4, Patients with dementia had sig
nificantly lower parietal metabolism than did at-risk subjects with AP
OE epsilon 4. Conclusions.-These results suggest that the inheritance
of APOE epsilon 4 is associated with reduced cerebral parietal metabol
ism and increased asymmetry in nondemented relatives at risk for proba
ble AD, Longitudinal study will determine if glucose metabolic measure
s provide a means to monitor experimental treatment responses during t
he early phases of the disorder.